Cigna Group Quarterly Report for Q1 Ended Mar 31, 2023

Summary

The Cigna Group reported a solid first quarter in 2023, demonstrating revenue growth and consistent operational performance. Total revenues increased by 6% year-over-year to $46.5 billion, driven by strong contributions from both the Evernorth Health Services and Cigna Healthcare segments. Pharmacy revenues saw a 5% increase, while premiums rose by 6%, reflecting growth in customer base and strategic pricing adjustments. Despite a slight dip in net investment income, the company maintained profitability, with shareholders' net income growing by 6% to $1.27 billion. The company's operational efficiency was evident, though selling, general, and administrative expenses saw an increase due to strategic investments aimed at future growth. Importantly, Cigna Healthcare experienced a significant 10% increase in medical customers, highlighting its expanding market reach. The company also continued its capital return strategy, with share repurchases and dividend payments, while managing its debt levels effectively, maintaining a debt-to-capitalization ratio of 42.2%.

Key Highlights

• 1Total revenues increased 6% to $46.5 billion, driven by growth across key segments.
• 2Shareholders' net income rose 6% to $1.27 billion, demonstrating sustained profitability.
• 3Cigna Healthcare experienced significant customer growth, with medical customers up 10%.
• 4Evernorth Health Services revenue increased 8%, fueled by pharmacy and fee-based services.
• 5The company maintained a healthy liquidity position with $8.1 billion in cash and short-term investments.
• 6Shareholders received $1.23 per share in dividends, reflecting a commitment to capital return.
• 7The company effectively manages its debt, with a debt-to-capitalization ratio of 42.2% as of March 31, 2023.

Frequently Asked Questions